Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 CAD | -1.06% | +20.78% | +564.29% |
Sales 2024 * | - | Sales 2025 * | 438K 318K | Capitalization | 211M 153M |
---|---|---|---|---|---|
Net income 2024 * | -15M -10.91M | Net income 2025 * | -19M -13.82M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 482 x |
P/E ratio 2024 * |
-12.4
x | P/E ratio 2025 * |
-10.6
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.81% |
Latest transcript on Medicenna Therapeutics Corp.
1 day | +15.57% | ||
1 week | +21.55% | ||
Current month | +21.55% | ||
1 month | +71.95% | ||
3 months | +526.67% | ||
6 months | +513.04% | ||
Current year | +571.43% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2.79 | -1.06% | 62 360 |
24-05-07 | 2.82 | +15.57% | 163,945 |
24-05-06 | 2.44 | +2.09% | 95,461 |
24-05-03 | 2.39 | +0.42% | 75,944 |
24-05-02 | 2.38 | +3.03% | 68,688 |
Delayed Quote Toronto S.E., May 07, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+571.43% | 154M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.39% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- MDNA Stock